These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12638448)

  • 1. [Treatment with NMDA antagonist controls neuron death. Even in severe dementia it is not too late].
    MMW Fortschr Med; 2003 Jan; 145(1-2):56. PubMed ID: 12638448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine for dementia?
    Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
    [No Abstract]   [Full Text] [Related]  

  • 5. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence.
    Danysz W; Parsons CG
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical relevance of memantine use].
    Sobów T
    Psychiatr Pol; 2004; 38(2):321-30. PubMed ID: 15307296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM
    Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating the full spectrum of dementia with memantine.
    Winblad B; Jelic V
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S41-6. PubMed ID: 12973749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The challenge of Alzheimer dementia].
    Pharm Unserer Zeit; 2003; 32(1):77. PubMed ID: 12577765
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
    Bullock R
    Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advanced dementia in Alzheimer's disease and memantine].
    Alberca R
    Rev Neurol; 2005 Feb 1-15; 40(3):173-9. PubMed ID: 15750904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine: update on the current evidence.
    Möbius HJ
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S47-54. PubMed ID: 12973750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Little behavior improvement with memantine].
    Potz-Biedermann C
    Med Monatsschr Pharm; 2005 Nov; 28(11):413-4. PubMed ID: 16309030
    [No Abstract]   [Full Text] [Related]  

  • 16. Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
    Dent Today; 1997 Feb; 16(2):29. PubMed ID: 9560599
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL; Lladó Plarrumaní A
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
    Muir KW
    Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.
    Grossberg GT; Pejović V; Miller ML; Graham SM
    Dement Geriatr Cogn Disord; 2009; 27(2):164-72. PubMed ID: 19194105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine: pharmacological properties and clinical uses.
    Kumar S
    Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.